Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTXR | RPHM | EPIX | ||
| Company | Citius Pharmaceuticals Inc | Reneo Pharmaceuticals Inc | Essa Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.0100 | 5.70 | 2.95 | ||
| High | 1.0300 | 6.17 | 3.19 | ||
| Low | 0.9600 | 5.55 | 2.94 | ||
| Last | 0.9758 | 5.86 | 3.00 | ||
| Change | -0.0442 | +0.15 | +0.03 | ||
| % Change | -4.33% | +2.63% | +1.01% | ||
| Volume | 679,100 | 138,600 | 182,300 | ||
| 20-Day Average Volume | 612,335 | 89,290 | 105,435 | ||
| Previous Close | 1.0200 | 5.71 | 2.97 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0983 | 4.11 | 3.06 | ||
| 20-Day Raw Stochastic | 5.85% | 90.49% | 47.72% | ||
| 20-Day Relative Strength | 39.27% | 74.21% | 50.37% | ||
| Weighted Alpha | -42.35 | +58.50 | -66.50 | ||
| Today's Opinion | 40% Sell | 88% Buy | 16% Buy | ||
| Previous Opinion | 24% Sell | 88% Buy | 24% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.39% since 03/13/23 | +35.33% since 03/13/23 | +8.30% since 03/13/23 | ||
| Low | 0.9600 on 03/20/23 | 4.17 on 03/15/23 | 2.81 on 03/14/23 | ||
| High | 1.0900 on 03/14/23 | 6.17 on 03/20/23 | 3.19 on 03/20/23 | ||
| 1-Month | |||||
| %Chg | -20.02% since 02/17/23 | +95.33% since 02/17/23 | -5.66% since 02/17/23 | ||
| Low | 0.9600 on 03/20/23 | 2.91 on 02/21/23 | 2.57 on 03/10/23 | ||
| High | 1.2300 on 02/23/23 | 6.17 on 03/20/23 | 3.47 on 03/02/23 | ||
| 3-Month | |||||
| %Chg | -6.17% since 12/20/22 | +166.36% since 12/20/22 | +18.11% since 12/20/22 | ||
| Low | 0.7700 on 12/30/22 | 2.02 on 12/22/22 | 2.29 on 12/23/22 | ||
| High | 1.4900 on 02/09/23 | 6.17 on 03/20/23 | 3.63 on 02/15/23 | ||
| 6-Month | |||||
| %Chg | -22.56% since 09/20/22 | +48.35% since 09/20/22 | +45.63% since 09/20/22 | ||
| Low | 0.7700 on 12/30/22 | 1.79 on 12/09/22 | 1.40 on 10/11/22 | ||
| High | 1.4900 on 02/09/23 | 6.17 on 03/20/23 | 5.16 on 10/28/22 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 142,719 | 143,746 | 132,276 | ||
| Shares Outstanding, K | 146,258 | 24,530 | 44,092 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -33,640,000 | -39,770,000 | -35,100,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -3,590,000 | -13,007,000 | -6,740,000 | ||
| 60-Month Beta | 1.40 | 0.61 | 2.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 02/10/23 | -0.53 on 11/08/22 | -0.15 on 02/07/23 | ||
| Latest Earnings Date | 05/11/23 | 03/22/23 | 05/09/23 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
